Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Article
Osteoporosis Drug Approval Highlights AJPB Week in Review
Author(s):
Top news of the week from The American Journal of Pharmacy Benefits.
5. FDA Grants Breakthrough Therapy, Fast Track Designations to Narcolepsy Treatment
The FDA has granted Harmony Biosciences a Breakthrough Therapy designation for pitolisant, an investigational therapy for the treatment of cataplexy in patients with narcolepsy.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Videos
Related Content
